Acute exposure to electronic cigarette components alters mRNA expression of pre-osteoblasts.
RNA sequencing
electronic cigarette
nicotine
pre‐osteoblast
propylene glycol
vegetable glycerin
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
15 Sep 2024
15 Sep 2024
Historique:
revised:
01
08
2024
received:
03
10
2023
accepted:
16
08
2024
medline:
1
9
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
ppublish
Résumé
The use of traditional nicotine delivery products such as tobacco has long been linked to detrimental health effects. However, little work to date has focused on the emerging market of aerosolized nicotine delivery known as electronic nicotine delivery systems (ENDS) or electronic cigarettes, and their potential for new effects on human health. Challenges studying these devices include heterogeneity in the formulation of the common components of most available ENDS, including nicotine and a carrier (commonly composed of propylene glycol and vegetable glycerin, or PG/VG). In the present study, we report on experiments interrogating the effects of major identified components in e-cigarettes. Specifically, the potential concomitant effects of nicotine and common carrier ingredients in commercial "vape" products are explored in vitro to inform the potential health effects on the craniofacial skeleton through novel vectors as compared to traditional tobacco products. MC3T3-E1 murine pre-osteoblast cells were cultured in vitro with clinically relevant liquid concentrations of nicotine, propylene glycol (PG), vegetable glycerin (VG), Nicotine+PG/VG, and the vape liquid of a commercial product (Juul). Cells were treated acutely for 24 h and RNA-Seq was utilized to determine segregating alteration in mRNA signaling. Influential gene targets identified with sparse partial least squares discriminant analysis (sPLS-DA) implemented in mixOmics were assessed using the PANTHER Classification system for molecular functions, biological processes, cellular components, and pathways of effect. Additional endpoint functional analyses were used to confirm cell cycle changes. The initial excitatory concentration (EC50) studied defined a target concentration of carrier PG/VG liquid that altered the cell cycle of the calvarial cells. Initial sPLS-DA analysis demonstrated the segregation of nicotine and non-nicotine exposures utilized in our in vitro modeling. Pathway analysis suggests a strong influence of nicotine exposures on cellular processes including metabolic processes and response to stimuli including autophagic flux. Further interrogation of the individual treatment conditions demonstrated segregation by treatment modality (Control, Nicotine, Carrier (PG+VG), Nicotine+PG/VG) along three dimensions best characterized by: latent variable 1 (PLSDA-1) showing strong segregation based on nicotine influence on cellular processes associated with cellular adhesion to collagen, osteoblast differentiation, and calcium binding and metabolism; latent variable 2 (PLSDA-2) showing strong segregation of influence based on PG+VG and Control influence on cell migration, survival, and cycle regulation; and latent variable 3 (PLSDA-3) showing strong segregation based on Nicotine and Control exposure influence on cell activity and growth and developmental processes. Further, gene co-expression network analysis implicates targets of the major pathway genes associated with bone growth and development, particularly craniofacial (FGF, Notch, TGFβ, WNT) and analysis of active subnetwork pathways found these additionally overrepresented in the Juul exposure relative to Nicotine+PG/VG. Finally, experimentation confirmed alterations in cell count, and increased evidence of cell stress (markers of autophagy), but no alteration in apoptosis. These data suggest concomitant treatment with Nicotine+PG/VG drives alterations in pre-osteoblast cell cycle signaling, specifically transcriptomic targets related to cell cycle and potentially cell stress. Although we suspected cell stress and well as cytotoxic effects of Nicotine+PG/VG, no great influence on apoptotic factors was observed. Further RNA-Seq analysis allowed for the direct interrogation of molecular targets of major pathways involved in bone and craniofacial development, each demonstrating segregation (altered signaling) due to e-cigarette-type exposure. These data have implications directed toward ENDS formulation as synergistic effects of Nicotine+PG/VG are evidenced here. Thus, future research will continue to interrogate how varied formulation of Nicotine+PG/VG affects overall cell functions in multiple vital systems.
Identifiants
pubmed: 39213037
doi: 10.1096/fj.202302014RRR
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
RNA, Messenger
0
Propylene Glycol
6DC9Q167V3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e70017Subventions
Organisme : NIDCR NIH HHS
ID : R03 DE026192
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002733
Pays : United States
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : UL1TR002733
Organisme : HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR)
ID : R03DE026192
Informations de copyright
© 2024 The Author(s). The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
Références
Bush AM, Holsinger JW Jr, Prybil LD. Employing the precautionary principle to evaluate the use of E‐cigarettes. Front Public Health. 2016;4:5.
Larsen PD. Vaping and adolescents: the next public health crisis. Rehabil Nurs. 2020;45:1‐2.
Raju SV, Rowe SM. Not simply the lesser of two evils. Am J Physiol Lung Cell Mol Physiol. 2018;314:L236‐L238.
Walley SC, Wilson KM, Winickoff JP, Groner J. A public health crisis: electronic cigarettes, vape, and JUUL. Pediatrics. 2019;143(6):e20182741.
Duell AK, Pankow JF, Peyton DH. Nicotine in tobacco product aerosols: ‘It's deja vu all over again’. Tob Control. 2019;29:656‐662.
Wu JC, Rhee JW, Sallam K. Electronic cigarettes: where there is smoke there is disease. J Am Coll Cardiol. 2019;74:3121‐3123.
Besaratinia A, Tommasi S. Vaping epidemic: challenges and opportunities. Cancer Causes Control. 2020;31:663‐667.
Creamer MR, Everett Jones S, Gentzke AS, Jamal A, King BA. Tobacco product use among high school students—youth risk behavior survey, United States, 2019. MMWR Suppl. 2020;69:56‐63.
Hammond D, Wackowski OA, Reid JL, O'Connor RJ. Use of JUUL E‐cigarettes among youth in the United States. Nicotine Tob Res. 2020;22:827‐832.
Parekh T, Desai R. A comparative analysis of E‐cigarette users and state‐specific prevalence change in the United States between 2017 and 2018. Cureus. 2020;12:e12079.
Wang G, Wu L. Healthy people 2020: social determinants of cigarette smoking and electronic cigarette smoking among youth in the United States 2010‐2018. Int J Environ Res Public Health. 2020;17(20):7503.
E‐cigarette and vape market size, share & trends analysis report by product (modular devices, rechargeable), By Distribution Channel (Online, Retail), By Region (APAC, North America), and segment forecasts, 2023–2030. Accessed September 29, 2023. https://www.grandviewresearch.com/industry‐analysis/e‐cigarette‐vaping‐market
E‐cigarettes. Accessed September 29, 2023. https://www.statista.com/outlook/cmo/tobacco‐products/e‐cigarettes/worldwide
E‐cigarette market – growth, trends, COVID‐19 impact and forecasts (2022 – 2027). Accessed September 29, 2023. https://www.researchandmarkets.com/reports/4703476/e‐cigarette‐market‐growth‐trends‐covid‐19
Cullen KA, Gentzke AS, Sawdey MD, et al. E‐cigarette use among youth in the United States, 2019. JAMA. 2019;322:2095‐2103.
Wang TW, Gentzke AS, Creamer MR, et al. Tobacco product use and associated factors among middle and high school students—United States, 2019. MMWR Surveill Summ. 2019;68:1‐22.
Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults—United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69:1736‐1742.
Gentzke AS, Wang TW, Jamal A, et al. Tobacco product use among middle and high school students—United States, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1881‐1888.
Meza R, Jimenez‐Mendoza E, Levy DT. Trends in tobacco use among adolescents by grade, sex, and race, 1991–2019. JAMA Netw Open. 2020;3:e2027465.
Pearson JL, Sharma E, Rui N, et al. Association of electronic nicotine delivery system use with cigarette smoking progression or reduction among young adults. JAMA Netw Open. 2020;3:e2015893.
Sokolovsky AW, Hertel AW, Micalizzi L, White HR, Hayes KL, Jackson KM. Preliminary impact of the COVID‐19 pandemic on smoking and vaping in college students. Addict Behav. 2021;115:106783.
Kalkhoran S, Glantz SA. E‐cigarettes and smoking cessation in real‐world and clinical settings: a systematic review and meta‐analysis. Lancet Respir Med. 2016;4:116‐128.
Rehan HS, Maini J, Hungin APS. Vaping versus smoking: a quest for efficacy and safety of E‐cigarette. Curr Drug Saf. 2018;13:92‐101.
Rom O, Pecorelli A, Valacchi G, Reznick AZ. Are E‐cigarettes a safe and good alternative to cigarette smoking? Ann N Y Acad Sci. 2015;1340:65‐74.
Farber HJ, Conrado Pacheco GM, Galiatsatos P, Folan P, Lamphere T, Pakhale S. Harms of electronic cigarettes: what the health care provider needs to know. Ann Am Thorac Soc. 2020;18:567‐572.
Kalkhoran S, Chang Y, Rigotti NA. Electronic cigarette use and cigarette abstinence over 2 years among U.S. smokers in the population assessment of tobacco and health study. Nicotine Tob Res. 2020;22:728‐733.
Keller‐Hamilton B, Lu B, Roberts ME, Berman ML, Root ED, Ferketich AK. Electronic cigarette use and risk of cigarette and smokeless tobacco initiation among adolescent boys: a propensity score matched analysis. Addict Behav. 2021;114:106770.
McAlinden KD, Eapen MS, Lu W, Sharma P, Sohal SS. The rise of electronic nicotine delivery systems and the emergence of electronic‐cigarette‐driven disease. Am J Physiol Lung Cell Mol Physiol. 2020;319:L585‐L595.
Osibogun O, Bursac Z, McKee M, Li T, Maziak W. Cessation outcomes in adult dual users of e‐cigarettes and cigarettes: the population assessment of tobacco and health cohort study, USA, 2013–2016. Int J Public Health. 2020;65:923‐936.
Patterson JG, LaPolt DT, Miranda AR, et al. Switching stories: user testimonials on juul.com continue to contradict JUUL's switch not equal cessation narrative. Tob Control. 2020;30:e37‐e40.
Fairchild AL, Bayer R, Lee JS. The E‐cigarette debate: what counts as evidence? Am J Public Health. 2019;109:1000‐1006.
Franks AS, Sando K, McBane S. Do electronic cigarettes have a role in tobacco cessation? Pharmacotherapy. 2018;38:555‐568.
Rowell TR, Tarran R. Will chronic e‐cigarette use cause lung disease? Am J Physiol Lung Cell Mol Physiol. 2015;309:L1398‐L1409.
Ellington S, Salvatore PP, Ko J, et al. Update: product, substance‐use, and demographic characteristics of hospitalized patients in a Nationwide outbreak of E‐cigarette, or vaping, product use‐associated lung injury ‐ United States, august 2019–January 2020. MMWR Morb Mortal Wkly Rep. 2020;69:44‐49.
King BA, Jones CM, Baldwin GT, Briss PA. The EVALI and youth vaping epidemics—implications for public health. N Engl J Med. 2020;382:689‐691.
Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use‐associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology. 2020;294(3):491‐505.
Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: characteristics of a Nationwide outbreak of E‐cigarette, or vaping, product use‐associated lung injury ‐ United States, august 2019–January 2020. MMWR Morb Mortal Wkly Rep. 2020;69:90‐94.
Salzman GA, Alqawasma M, Asad H. Vaping associated lung injury (EVALI): An explosive United States epidemic. Mo Med. 2019;116:492‐496.
Saqi A, Mukhopadhyay S, Butt Y, et al. E‐cigarette or vaping product use‐associated lung injury: what is the role of cytologic assessment? Cancer Cytopathol. 2020;128:371‐380.
Arons MM, Barnes SR, Cheng R, et al. Examining the temporality of vitamin E acetate in illicit THC‐containing e‐cigarette, or vaping, products from a public health and law enforcement response to EVALI ‐ Utah, 2018–2020. Int J Drug Policy. 2020;88:103026.
Cobb NK, Solanki JN. E‐cigarettes, vaping devices, and acute lung injury. Respir Care. 2020;65:713‐718.
Rao DR, Maple KL, Dettori A, et al. Clinical features of E‐cigarette, or vaping, product use‐associated lung injury in teenagers. Pediatrics. 2020;146(1):e20194104.
Chatterjee S, Caporale A, Tao JQ, et al. Acute e‐cig inhalation impacts vascular health: a study in smoking naive subjects. Am J Physiol Heart Circ Physiol. 2021;320:H144‐H158.
Rohde JA, Noar SM, Mendel JR, et al. E‐cigarette health harm awareness and discouragement: implications for health communication. Nicotine Tob Res. 2020;22:1131‐1138.
Ganesan SM, Dabdoub SM, Nagaraja HN, et al. Adverse effects of electronic cigarettes on the disease‐naive oral microbiome. Sci Adv. 2020;6:eaaz0108.
Franck C, Filion KB, Kimmelman J, Grad R, Eisenberg MJ. Ethical considerations of e‐cigarette use for tobacco harm reduction. Respir Res. 2016;17:53.
Kaisar MA, Prasad S, Liles T, Cucullo L. A decade of e‐cigarettes: limited research & unresolved safety concerns. Toxicology. 2016;365:67‐75.
Greene RM, Pisano MM. Developmental toxicity of e‐cigarette aerosols. Birth Defects Res. 2019;111:1294‐1301.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. E‐cigarette use among youth and young adults: A report of the surgeon general [Internet]. Centers for Disease Control and Prevention (US); 2016.
Gaiha SM, Lempert LK, Halpern‐Felsher B. Underage youth and young adult e‐cigarette use and access before and during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3:e2027572.
Clapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17:79.
Kienhuis AS, Soeteman‐Hernandez LG, Bos PM, Cremers HW, Klerx WN, Talhout R. Potential harmful health effects of inhaling nicotine‐free shisha‐pen vapor: a chemical risk assessment of the main components propylene glycol and glycerol. Tob Induc Dis. 2015;13:15.
Larcombe AN, Janka MA, Mullins BJ, Berry LJ, Bredin A, Franklin PJ. The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice. Am J Physiol Lung Cell Mol Physiol. 2017;313:L67‐L79.
Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248‐260.
Holbrook BD. The effects of nicotine on human fetal development. Birth Defects Res C Embryo Today. 2016;108:181‐192.
Kim S, Oancea SC. Electronic cigarettes may not be a “safer alternative” of conventional cigarettes during pregnancy: evidence from the nationally representative PRAMS data. BMC Pregnancy Childbirth. 2020;20:557.
Maddahi MS, Dolatian M, Khoramabadi M, Talebi A. Correlation of maternal‐fetal attachment and health practices during pregnancy with neonatal outcomes. Electron Physician. 2016;8:2639‐2644.
Pauly JR, Slotkin TA. Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr. 2008;97:1331‐1337.
Ratsch A, Bogossian F. Smokeless tobacco use in pregnancy: an integrative review of the literature. Int J Public Health. 2014;59:599‐608.
Whittington JR, Simmons PM, Phillips AM, et al. The use of electronic cigarettes in pregnancy: a review of the literature. Obstet Gynecol Surv. 2018;73:544‐549.
Alderman BW, Bradley CM, Greene C, Fernbach SK, Baron AE. Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology. 1994;50:13‐18.
Baroni T, Bellucci C, Lilli C, et al. Human cleft lip and palate fibroblasts and normal nicotine‐treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism. J Cell Physiol. 2010;222:748‐756.
Bradley CM, Alderman BW, Williams MA, et al. Parental occupations as risk factors for craniosynostosis in offspring. Epidemiology. 1995;6:306‐310.
Carmichael SL, Ma C, Rasmussen SA, et al. Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol. 2008;82:78‐85.
Carmichael SL, Rasmussen SA, Lammer EJ, Ma C, Shaw GM, National Birth Defects Prevention, S. Craniosynostosis and nutrient intake during pregnancy. Birth Defects Res A Clin Mol Teratol. 2010;88:1032‐1039.
Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009;65:325‐330.
Farooq S, Morton J, Lloyd M, Krishna ST. The influence of epigenetic factors in four pairs of twins with non‐syndromic Craniosynostosis. J Craniofac Surg. 2020;31:283‐285.
Gunnerbeck A, Edstedt Bonamy AK, Wikstrom AK, Granath F, Wickstrom R, Cnattingius S. Maternal snuff use and smoking and the risk of oral cleft malformations—a population‐based cohort study. PLoS ONE. 2014;9:e84715.
Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17:589‐604.
Honein MA, Rasmussen SA. Further evidence for an association between maternal smoking and craniosynostosis. Teratology. 2000;62:145‐146.
Hoyt AT, Shumate CJ, Canfield MA, et al. Selected acculturation factors and birth defects in the National Birth Defects Prevention Study, 1997–2011. Birth Defects Res. 2019;111:598‐612.
Johnston MC, Bronsky PT. Prenatal craniofacial development: new insights on normal and abnormal mechanisms. Crit Rev Oral Biol Med. 1995;6:368‐422.
Jugessur A, Wilcox AJ, Murray JC, et al. Assessing the impact of nicotine dependence genes on the risk of facial clefts: an example of the use of national registry and biobank data. Nor Epidemiol. 2012;21:241‐250.
Kallen K. Maternal smoking and craniosynostosis. Teratology. 1999;60:146‐150.
Root S. Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology. 1995;51:289‐291.
Shaw GM, Carmichael SL, Vollset SE, et al. Mid‐pregnancy cotinine and risks of orofacial clefts and neural tube defects. J Pediatr. 2009;154:17‐19.
Su PH, Chen JY, Lee IC, Ng YY, Hu JM, Chen SJ. Pfeiffer‐like syndrome with holoprosencephaly: a newborn with maternal smoking and alcohol exposure. Pediatr Neonatol. 2009;50:234‐238.
Zeiger JS, Beaty TH, Hetmanski JB, et al. Genetic and environmental risk factors for sagittal craniosynostosis. J Craniofac Surg. 2002;13:602‐606.
Murray JC. Gene/environment causes of cleft lip and/or palate. Clin Genet. 2002;61:248‐256.
Soulet S, Sussman RA. A critical review of recent literature on metal contents in E‐cigarette aerosol. Toxics. 2022;10(9):510.
Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;192:29‐60.
Goldenson NI, Fearon IM, Buchhalter AR, Henningfield JE. An open‐label, randomized, controlled, crossover study to assess nicotine pharmacokinetics and subjective effects of the JUUL system with three nicotine concentrations relative to combustible cigarettes in adult smokers. Nicotine Tob Res. 2021;23:947‐955.
Omaiye EE, McWhirter KJ, Luo W, Pankow JF, Talbot P. High‐nicotine electronic cigarette products: toxicity of JUUL fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations. Chem Res Toxicol. 2019;32:1058‐1069.
Prochaska JJ, Vogel EA, Benowitz N. Nicotine delivery and cigarette equivalents from vaping a JUULpod. Tob Control. 2022;31:e88‐e93.
Talih S, Salman R, El‐Hage R, et al. Characteristics and toxicant emissions of JUUL electronic cigarettes. Tob Control. 2019;28:678‐680.
Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA‐seq aligner. Bioinformatics. 2013;29:15‐21.
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923‐930.
Chen Y, Lun A, Smyth GK. From reads to genes to pathways: differential expression analysis of RNA‐Seq experiments using Rsubread and the edgeR quasi‐likelihood pipeline [version 2; peer review: 5 approved]. F1000Res. 2016;5:1438.
Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139‐140.
Rohart F, Gautier B, Singh A, Le Cao KA. mixOmics: an R package for 'omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13:e1005752.
Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54:343‐349.
Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real‐time PCR data. BMC Bioinform. 2006;7:85.
Lê Cao KA, Boitard S, Besse P. Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinform 2011;22(12):253.
Ornitz DM, Marie PJ. Fibroblast growth factor signaling in skeletal development and disease. Genes Dev. 2015;29:1463‐1486.
Agrawal S, Maity S, AlRaawi Z, Al‐Ameer M, Kumar TKS. Targeting drugs against fibroblast growth factor(s)‐induced cell signaling. Curr Drug Targets. 2021;22:214‐240.
Lodh S, O'Hare EA, Zaghloul NA. Primary cilia in pancreatic development and disease. Birth Defects Res C Embryo Today. 2014;102:139‐158.
Ndlovu R, Deng LC, Wu J, Li XK, Zhang JS. Fibroblast growth factor 10 in pancreas development and pancreatic cancer. Front Genet. 2018;9:482.
Warburton D, Bellusci S. The molecular genetics of lung morphogenesis and injury repair. Paediatr Respir Rev. 2004;5 suppl A:S283‐S287.
Park SR, Kim JW, Jun HS, Roh JY, Lee HY, Hong IS. Stem cell Secretome and its effect on cellular mechanisms relevant to wound healing. Mol Ther. 2018;26:606‐617.
Tan X, Tao Q, Li G, et al. Fibroblast growth factor 2 attenuates renal ischemia‐reperfusion injury via inhibition of endoplasmic reticulum stress. Front Cell Dev Biol. 2020;8:147.
Li X. The FGF metabolic axis. Front Med. 2019;13:511‐530.
Liao J, Huang Y, Wang Q, et al. Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development. Cell Mol Life Sci. 2022;79:158.
Miraoui H, Marie PJ. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal. 2010;3:re9.
Moosa S, Wollnik B. Altered FGF signalling in congenital craniofacial and skeletal disorders. Semin Cell Dev Biol. 2016;53:115‐125.
Neben CL, Merrill AE. Signaling pathways in craniofacial development: insights from rare skeletal disorders. Curr Top Dev Biol. 2015;115:493‐542.
Senarath‐Yapa K, Chung MT, McArdle A, et al. Craniosynostosis: molecular pathways and future pharmacologic therapy. Organogenesis. 2012;8:103‐113.
Wang H, Zang C, Liu XS, Aster JC. The role of notch receptors in transcriptional regulation. J Cell Physiol. 2015;230:982‐988.
Wang MM. Notch signaling and notch signaling modifiers. Int J Biochem Cell Biol. 2011;43:1550‐1562.
Vazquez‐Ulloa E, Lin KL, Lizano M, Sahlgren C. Reversible and bidirectional signaling of notch ligands. Crit Rev Biochem Mol Biol. 2022;57:377‐398.
Zamfirescu AM, Yatsenko AS, Shcherbata HR. Notch signaling sculpts the stem cell niche. Front Cell Dev Biol. 2022;10:1027222.
Khosla R, Vyas AK, Trehanpati N. Dichotomy of Notch signalling in regulating tumour immune surveillance. Scand J Immunol. 2019;89:e12744.
Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7:131.
Huang J, Chen Y, Tang C, et al. The relationship between substrate topography and stem cell differentiation in the musculoskeletal system. Cell Mol Life Sci. 2019;76:505‐521.
Kranc W, Budna J, Kahan R, et al. Molecular basis of growth, proliferation, and differentiation of mammalian follicular granulosa cells. J Biol Regul Homeost Agents. 2017;31:1‐8.
Tomishima M. Neural induction – Dual SMAD inhibition. StemBook [Internet]. Harvard Stem Cell Institute; 2012:2008.
Vimalraj S, Selvamurugan N. MicroRNAs: synthesis, gene regulation and osteoblast differentiation. Curr Issues Mol Biol. 2013;15:7‐18.
Anbara T, Sharifi M, Aboutaleb N. Endothelial to mesenchymal transition in the cardiogenesis and cardiovascular diseases. Curr Cardiol Rev. 2020;16:306‐314.
Du Q, Zhang D, Zhuang Y, Xia Q, Wen T, Jia H. The molecular genetics of Marfan syndrome. Int J Med Sci. 2021;18:2752‐2766.
Lu X, Gong J, Dennery PA, Yao H. Endothelial‐to‐mesenchymal transition: pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases. Biochem Pharmacol. 2019;168:100‐107.
Takeda N, Yagi H, Hara H, et al. Pathophysiology and management of cardiovascular manifestations in Marfan and Loeys‐Dietz syndromes. Int Heart J. 2016;57:271‐277.
Inestrosa NC, Varela‐Nallar L. Wnt signalling in neuronal differentiation and development. Cell Tissue Res. 2015;359:215‐223.
Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014;13:513‐532.
Yang Y. Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis. Birth Defects Res C Embryo Today. 2003;69:305‐317.
Duan P, Bonewald LF. The role of the wnt/beta‐catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 2016;77:23‐29.
Huang P, Yan R, Zhang X, Wang L, Ke X, Qu Y. Activating Wnt/beta‐catenin signaling pathway for disease therapy: challenges and opportunities. Pharmacol Ther. 2019;196:79‐90.
Maeda K, Kobayashi Y, Koide M, et al. The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci. 2019;20(22):5525.
Martínez‐Gil N, Ugartondo N, Grinberg D, Balcells S. Wnt pathway extracellular components and their essential roles in bone homeostasis. Genes (Basel). 2022;13(1):138.
Fan H, Yuan F, Yun Y, et al. MicroRNA‐34a mediates ethanol‐induced impairment of neural differentiation of neural crest cells by targeting autophagy‐related gene 9a. Exp Neurol. 2019;320:112981.
Thomas N, Choi HK, Wei X, et al. Autophagy regulates craniofacial bone acquisition. Calcif Tissue Int. 2019;105:518‐530.
Wang XY, Li S, Wang G, et al. High glucose environment inhibits cranial neural crest survival by activating excessive autophagy in the chick embryo. Sci Rep. 2015;5:18321.
Cray JJ Jr, Weinberg SM, Parsons TE, Howie RN, Elsalanty M, Yu JC. Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in mice. Birth Defects Res A Clin Mol Teratol. 2014;100:912‐923.
Durham E, Jen S, Wang L, et al. Effects of citalopram on sutural and Calvarial cell processes. PLoS ONE. 2015;10:e0139719.
Herberg S, Kondrikova G, Periyasamy‐Thandavan S, et al. Inkjet‐based biopatterning of SDF‐1beta augments BMP‐2‐induced repair of critical size calvarial bone defects in mice. Bone. 2014;67:95‐103.
Izumiya M, Haniu M, Ueda K, et al. Evaluation of MC3T3‐E1 cell osteogenesis in different cell culture media. Int J Mol Sci. 2021;22(14):7752.
Zhou HY, Takita H, Fujisawa R, Mizuno M, Kuboki Y. Stimulation by bone sialoprotein of calcification in osteoblast‐like MC3T3‐E1 cells. Calcif Tissue Int. 1995;56:403‐407.
Gullihorn L, Karpman R, Lippiello L. Differential effects of nicotine and smoke condensate on bone cell metabolic activity. J Orthop Trauma. 2005;19:17‐22.
Ko CH, Chan RL, Siu WS, et al. Deteriorating effect on bone metabolism and microstructure by passive cigarette smoking through dual actions on osteoblast and osteoclast. Calcif Tissue Int. 2015;96:389‐400.
Nishino K, Tamai K, Orita K, Hashimoto Y, Nakamura H. Heated tobacco products impair cell viability, osteoblastic differentiation, and bone fracture‐healing. J Bone Joint Surg Am. 2021;103:2024‐2031.
Ren Q, Wu Y, Ma J, Shan Q, Liu S, Liu Y. Carbon black‐induced detrimental effect on osteoblasts at low concentrations: remarkably compromised differentiation without significant cytotoxicity. Ecotoxicol Environ Saf. 2019;178:211‐220.
Sato T, Abe T, Nakamoto N, et al. Nicotine induces cell proliferation in association with cyclin D1 up‐regulation and inhibits cell differentiation in association with p53 regulation in a murine pre‐osteoblastic cell line. Biochem Biophys Res Commun. 2008;377:126‐130.
Yang J, Shao SY, Chen WQ, Chen C, Zhang SM, Qiu J. Cigarette smoke extract exposure: effects on the interactions between titanium surface and osteoblasts. Biomed Res Int. 2019;2019:8759568.
Yuhara S, Kasagi S, Inoue A, Otsuka E, Hirose S, Hagiwara H. Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone. Eur J Pharmacol. 1999;383:387‐393.
Durham E, Howie RN, Warren G, LaRue A, Cray J. Direct effects of nicotine exposure on murine calvaria and calvarial cells. Sci Rep. 2019;9:3805.
Daffner SD, Waugh S, Norman TL, Mukherjee N, France JC. Nicotine increases osteoblast activity of induced bone marrow stromal cells in a dose‐dependent manner: an in vitro cell culture experiment. Global Spine J. 2012;2:153‐158.
Rothem DE, Rothem L, Dahan A, Eliakim R, Soudry M. Nicotinic modulation of gene expression in osteoblast cells, MG‐63. Bone. 2011;48:903‐909.
Li D, Shen C, Liu L, et al. PKM2 regulates cigarette smoke‐induced airway inflammation and epithelial‐to‐mesenchymal transition via modulating PINK1/Parkin‐mediated mitophagy. Toxicology. 2022;477:153251.
Lin H, Zhang X, Feng N, et al. LncRNA LCPAT1 mediates smoking/ particulate matter 2.5‐induced cell autophagy and epithelial‐mesenchymal transition in lung cancer cells via RCC2. Cell Physiol Biochem. 2018;47:1244‐1258.
Ryter SW, Choi AM. Autophagy in the lung. Proc Am Thorac Soc. 2010;7:13‐21.
Severino ME, Richardson LS, Kacerovsky M, Menon R. Histologic evidence of epithelial‐mesenchymal transition and autophagy in human fetal membranes. Am J Pathol. 2024;194:684‐692.
Xiang K, Ren M, Liu F, et al. Tobacco toxins trigger bone marrow mesenchymal stem cells aging by inhibiting mitophagy. Ecotoxicol Environ Saf. 2024;277:116392.
Getiye Y, Peterson MR, Phillips BD, Carrillo D, Bisha B, He G. E‐cigarette exposure with or without heating the e‐liquid induces differential remodeling in the lungs and right heart of mice. J Mol Cell Cardiol. 2022;168:83‐95.
Go YY, Mun JY, Chae SW, Chang J, Song JJ. Comparison between in vitro toxicities of tobacco‐ and menthol‐flavored electronic cigarette liquids on human middle ear epithelial cells. Sci Rep. 2020;10:2544.
Scieszka DP, Garland D, Hunter R, et al. Multi‐omic assessment shows dysregulation of pulmonary and systemic immunity to e‐cigarette exposure. Respir Res. 2023;24:138.
Caruso M, Emma R, Rust S, et al. Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes. Regul Toxicol Pharmacol. 2021;125:105018.
Abaricia JO, Whitehead AJ, Kandalam S, et al. E‐cigarette aerosol mixtures inhibit biomaterial‐induced osseointegrative cell phenotypes. Materialia (Oxf). 2021;20:101241.
Cyprus GN, Overlin JW, Hotchkiss KM, Kandalam S, Olivares‐Navarrete R. Cigarette smoke increases pro‐inflammatory markers and inhibits osteogenic differentiation in experimental exposure model. Acta Biomater. 2018;76:308‐318.
Lu Y, Di YP, Chang M, et al. Cigarette smoke‐associated inflammation impairs bone remodeling through NFkappaB activation. J Transl Med. 2021;19:163.
Martinez IKC, Sparks NRL, Madrid JV, Talbot P, Zur Nieden NI. Exposure to cigarette smoke impedes human osteoblast differentiation independently of nicotine. Nicotine Tob Res. 2022;24:1921‐1926.
Kim BS, Kim SJ, Kim HJ, et al. Effects of nicotine on proliferation and osteoblast differentiation in human alveolar bone marrow‐derived mesenchymal stem cells. Life Sci. 2012;90:109‐115.
Theiss SM, Boden SD, Hair G, Titus L, Morone MA, Ugbo J. The effect of nicotine on gene expression during spine fusion. Spine (Phila Pa 1976). 2000;25:2588‐2594.
Dai W, Shi J, Siddarth P, et al. Effects of electronic cigarette exposure on myocardial infarction and No‐reflow, and cardiac function in a rat model. J Cardiovasc Pharmacol Ther. 2023;28:10742484231155992.
Ibhagui OY, Li D, Han H, et al. Early detection and staging of lung fibrosis enabled by collagen‐targeted MRI protein contrast agent. Chem Biomed Imaging. 2023;1:268‐285.
Kelesidis T, Sharma M, Sharma E, Ruedisueli I, Tran E, Middlekauff HR. Chronic electronic cigarette use and atherosclerosis risk in young people: a cross‐sectional study‐brief report. Arterioscler Thromb Vasc Biol. 2023;43:1713‐1718.
Shi H, Fan X, Horton A, et al. The effect of electronic‐cigarette vaping on cardiac function and angiogenesis in mice. Sci Rep. 2019;9:4085.
Suryadinata RV, Wirjatmadi B. The molecular pathways of lung damage by E‐cigarettes in male Wistar rats. Sultan Qaboos Univ Med J. 2021;21:436‐441.
Wang Q, Lucas JH, Pang C, Zhao R, Rahman I. Tobacco and menthol flavored nicotine‐free electronic cigarettes induced inflammation and dysregulated repair in lung fibroblast and epithelium. Respir Res. 2024;25(1):23.
Wang Q, Sundar IK, Li D, et al. E‐cigarette‐induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS‐CoV‐2 Covid‐19 ACE2 receptor regulation. Respir Res 2020;21(1):154.
Wawryk‐Gawda, E., Chylinska‐Wrzos, P., M, K. Z., Chlapek, K., and Jodlowska‐Jedrych, B. (2020) Lung histomorphological alterations in rats exposed to cigarette smoke and electronic cigarette vapour. Exp Ther Med 19, 2826–2832.
Kennedy P, Saloky K, Yadavalli A, et al. Nicotine exposure via electronic cigarettes significantly impedes biomechanical healing properties of tendon healing in a rat model. Art Ther. 2021;37:3170‐3176.
Akram Z, Aati S, Alrahlah A, Vohra F, Fawzy A. Longitudinal evaluation of clinical, spectral and tissue degradation biomarkers in progression of periodontitis among cigarette and electronic cigarette smokers. J Dent. 2021;109:103678.
Sancilio S, Gallorini M, Cataldi A, Sancillo L, Rana RA, di Giacomo V. Modifications in human Oral fibroblast ultrastructure, collagen production, and lysosomal compartment in response to electronic cigarette fluids. J Periodontol. 2017;88:673‐680.
Otero CE, Noeker JA, Brown MM, et al. Electronic cigarette liquid exposure induces flavor‐dependent osteotoxicity and increases expression of a key bone marker, collagen type I. J Appl Toxicol. 2019;39:888‐898.
Wavreil FDM, Heggland SJ. Cinnamon‐flavored electronic cigarette liquids and aerosols induce oxidative stress in human osteoblast‐like MG‐63 cells. Toxicol Rep. 2020;7:23‐29.
Ma L, Zheng LW, Sham MH, Cheung LK. Effect of nicotine on gene expression of angiogenic and osteogenic factors in a rabbit model of bone regeneration. J Oral Maxillofac Surg. 2010;68:777‐781.
Marinucci L, Bodo M, Balloni S, Locci P, Baroni T. Sub‐toxic nicotine concentrations affect extracellular matrix and growth factor signaling gene expressions in human osteoblasts. J Cell Physiol. 2014;229:2038‐2048.
Nakayama Y, Mezawa M, Araki S, et al. Nicotine suppresses bone sialoprotein gene expression. J Periodontal Res. 2009;44:657‐663.
Cheng Y, Gu W, Zhang G, Guo X. Notch1 activation of Jagged1 contributes to differentiation of mesenchymal stem cells into endothelial cells under cigarette smoke extract exposure. BMC Pulm Med. 2022;22:139.
Chiappara G, Di Vincenzo S, Sangiorgi C, et al. Cigarette smoke upregulates Notch‐1 signaling pathway and promotes lung adenocarcinoma progression. Toxicol Lett. 2022;355:31‐40.
Di Vincenzo S, Ninaber DK, Cipollina C, Ferraro M, Hiemstra PS, Pace E. Cigarette smoke impairs airway epithelial wound repair: role of modulation of epithelial‐mesenchymal transition processes and notch‐1 signaling. Antioxidants (Basel). 2022;11(10):2018.
Garcia‐Ryde M, van der Burg NMD, Larsson CE, et al. Lung fibroblasts from chronic obstructive pulmonary disease subjects have a deficient gene expression response to cigarette smoke extract compared to healthy. Int J Chron Obstruct Pulmon Dis. 2023;18:2999‐3014.
Kim CW, Lee SM, Ko EB, et al. Inhibitory effects of cigarette smoke extracts on neural differentiation of mouse embryonic stem cells. Reprod Toxicol. 2020;95:75‐85.
Qiu J, Zhang YN, Zheng X, Zhang P, Ma G, Tan H. Notch promotes DNMT‐mediated hypermethylation of Klotho leads to COPD‐related inflammation. Exp Lung Res. 2018;44:368‐377.
Sun QR, Wu DY, Zhang JJ, et al. Nicotine exposure disrupts placental development via the Notch signaling pathway. Reproduction. 2023;166:187‐197.
Xie C, Zhu J, Jiang Y, et al. Sulforaphane inhibits the acquisition of tobacco smoke‐induced lung cancer stem cell‐like properties via the IL‐6/DeltaNp63alpha/Notch axis. Theranostics. 2019;9:4827‐4840.
Zong D, Li J, Cai S, et al. Notch1 regulates endothelial apoptosis via the ERK pathway in chronic obstructive pulmonary disease. Am J Physiol Cell Physiol. 2018;315:C330‐C340.
Liang D, Wang KJ, Tang ZQ, et al. Effects of nicotine on the metabolism and gene expression profile of Sprague‐Dawley rat primary osteoblasts. Mol Med Rep. 2018;17:8269‐8281.
Aspera‐Werz RH, Chen T, Ehnert S, Zhu S, Fröhlich T, Nussler AK. Cigarette smoke induces the risk of metabolic bone diseases: transforming growth factor beta signaling impairment via dysfunctional primary cilia affects migration, proliferation, and differentiation of human mesenchymal stem cells. Int J Mol Sci. 2019;20(12):2915.
Negri BM, Pimentel SP, Casati MZ, Cirano FR, Casarin RC, Ribeiro FV. Impact of a chronic smoking habit on the osteo‐immunoinflammatory mediators in the peri‐implant fluid of clinically healthy dental implants. Arch Oral Biol. 2016;70:55‐61.
Ma L, Zwahlen RA, Zheng LW, Sham MH. Influence of nicotine on the biological activity of rabbit osteoblasts. Clin Oral Implants Res. 2011;22:338‐342.
Ha TN, Madison MC, Kheradmand F, Altman KW. Laryngeal inflammatory response to smoke and vape in a murine model. Am J Otolaryngol. 2019;40:89‐92.
Jaleel Z, Blasberg E, Troiano C, et al. Association of vaping with decreased vascular endothelial growth factor expression and decreased microvessel density in cutaneous wound healing tissue in rats. Wound Repair Regen. 2021;29:1024‐1034.
Carlier FM, Dupasquier S, Ambroise J, et al. Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease. EBioMedicine. 2020;61:103034.
Cui W, Zhang Z, Zhang P, et al. Nrf2 attenuates inflammatory response in COPD/emphysema: crosstalk with Wnt3a/beta‐catenin and AMPK pathways. J Cell Mol Med. 2018;22:3514‐3525.
Li P, Han X, Li J, et al. Aerobic exercise training engages the canonical wnt pathway to improve pulmonary function and inflammation in COPD. BMC Pulm Med. 2024;24:236.
Lin X, Li Y, Gong L, et al. Tempo‐spatial regulation of the Wnt pathway by FAM13A modulates the stemness of alveolar epithelial progenitors. EBioMedicine. 2021;69:103463.
Moon HG, Zheng Y, An CH, Kim YK, Jin Y. CCN1 secretion induced by cigarette smoking extracts augments IL‐8 release from bronchial epithelial cells. PLoS ONE. 2013;8:e68199.
Unachukwu U, Trischler J, Goldklang M, Xiao R, D'Armiento J. Maternal smoke exposure decreases mesenchymal proliferation and modulates Rho‐GTPase‐dependent actin cytoskeletal signaling in fetal lungs. FASEB J. 2017;31:2340‐2351.
Yu W, Hu B, Shi X, et al. Nicotine inhibits osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress through canonical Wnt pathway and alpha7 nicotinic acetylcholine receptor. J Periodontal Res. 2018;53:555‐564.
Zhang D, Dai J, Cao Y, Wang Z, Qiao Z, Qiao Z. Nicotine exposure of male mice protects offspring against carbon tetrachloride‐induced acute liver injury. J Biochem Mol Toxicol. 2022;36:e23069.
Zhang D, Dai J, Zhang M, et al. Paternal nicotine exposure promotes hepatic fibrosis in offspring. Toxicol Lett. 2021;343:44‐55.
Zhou Z, Li B, Dong Z, et al. Nicotine deteriorates the osteogenic differentiation of periodontal ligament stem cells through alpha7 nicotinic acetylcholine receptor regulating Wnt pathway. PLoS ONE. 2013;8:e83102.
Pennings JLA, Havermans A, Pauwels CGGM, Krüsemann EJZ, Visser WF, Talhout R. Comprehensive Dutch market data analysis shows that e‐liquids with nicotine salts have both higher nicotine and flavour concentrations than those with free‐base nicotine. Tob Control. 2023;32:e78‐e82.
Crosswhite M, Wade C, Jeong LN, Gillman IG. Letter to the editor regarding characterizing the chemical landscape in commercial E‐cigarette liquids and aerosols by liquid chromatography‐high‐resolution mass spectrometry. Chem Res Toxicol. 2022;35:3‐4.
Crosswhite MR, Bailey PC, Jeong LN, et al. Non‐targeted chemical characterization of JUUL virginia tobacco flavored aerosols using liquid and gas chromatography. Separations. 2021;8:130.
Hua M, Luo W, Khachatoorian C, et al. Exposure, retention, exhalation, symptoms, and environmental accumulation of chemicals during JUUL vaping. Chem Res Toxicol. 2023;36:492‐507.
Talih S, Salman R, Soule E, et al. Electrical features, liquid composition and toxicant emissions from ‘pod‐mod’‐like disposable electronic cigarettes. Tob Control. 2022;31:667‐670.
Tehrani MW, Newmeyer MN, Rule AM, Prasse C. Characterizing the chemical landscape in commercial E‐cigarette liquids and aerosols by liquid chromatography‐high‐resolution mass spectrometry. Chem Res Toxicol. 2021;34:2216‐2226.
Tehrani MW, Newmeyer MN, Rule AM, Prasse C. Response to letter to the editor regarding characterizing the chemical landscape in commercial E‐cigarette liquids and aerosols by liquid chromatography‐high‐resolution mass spectrometry. Chem Res Toxicol. 2022;35:1‐2.
Shaito A, Saliba J, Husari A, et al. Electronic cigarette smoke impairs normal mesenchymal stem cell differentiation. Sci Rep. 2017;7:14281.
Durham E, Howie RN, Larson N, LaRue A, Cray J. Pharmacological exposures may precipitate craniosynostosis through targeted stem cell depletion. Stem Cell Res. 2019;40:101528.
Gruber MD, Gibbs D, Vignolles‐Jeong J, Viljoen S, Grossbach AJ, Xu D. The effects of nicotine‐ and cigarette‐related products on osteogenesis, bone formation, and bone mineralization: a systematic review. Neurosurgery. 2023;93:247‐256.
Breland A, McCubbin A, Ashford K. Electronic nicotine delivery systems and pregnancy: recent research on perceptions, cessation, and toxicant delivery. Birth Defects Res. 2019;111:1284‐1293.
Suter MA, Mastrobattista J, Sachs M, Aagaard K. Is there evidence for potential harm of electronic cigarette use in pregnancy? Birth Defects Res A Clin Mol Teratol. 2015;103:186‐195.
Tonstad S, Gustavsson G, Kruse E, Walmsley JM, Westin A. Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy. Nicotine Tob Res. 2014;16:1266‐1271.
Auschwitz E, Almeda J, Andl CD. Mechanisms of E‐cigarette vape‐induced epithelial cell damage. Cells. 2023;12(21):2552.
Forest V, Mercier C, Pourchez J. Considerations on dosimetry for in vitro assessment of e‐cigarette toxicity. Respir Res. 2022;23:358.
Marrocco A, Singh D, Christiani DC, Demokritou P. E‐cigarette vaping associated acute lung injury (EVALI): state of science and future research needs. Crit Rev Toxicol. 2022;52:188‐220.
Quail MT. Nicotine toxicity: protecting children from e‐cigarette exposure. Nursing. 2020;50:44‐48.
Gordon T, Karey E, Rebuli ME, Escobar YH, Jaspers I, Chen LC. E‐cigarette toxicology. Annu Rev Pharmacol Toxicol. 2022;62:301‐322.
Li S, Xu W, Xing Z, et al. A conditional knockout mouse model reveals a critical role of PKD1 in osteoblast differentiation and bone development. Sci Rep. 2017;7:40505.
Maruyama T, Jiang M, Abbott A, et al. Rap1b is an effector of Axin2 regulating crosstalk of signaling pathways during skeletal development. J Bone Miner Res. 2017;32:1816‐1828.
Nguyen, B. H., Ishii, M., Maxson, R. E., and Wang, J. (2018) Culturing and manipulation of O9‐1 neural crest cells. J Vis Exp.
Pfaff MJ, Xue K, Li L, Horowitz MC, Steinbacher DM, Eswarakumar JVP. FGFR2c‐mediated ERK‐MAPK activity regulates coronal suture development. Dev Biol. 2016;415:242‐250.
Zhao X, Le TP, Erhardt S, Findley TO, Wang J. Hippo‐Yap pathway orchestrates neural crest ontogenesis. Front Cell Dev Biol. 2021;9:706623.
Dickinson AJG, Turner SD, Wahl S, Kennedy AE, Wyatt BH, Howton DA. E‐liquids and vanillin flavoring disrupts retinoic acid signaling and causes craniofacial defects in Xenopus embryos. Dev Biol. 2022;481:14‐29.
Williams AL, Bohnsack BL. What's retinoic acid got to do with it? Retinoic acid regulation of the neural crest in craniofacial and ocular development. Genesis. 2019;57:e23308.
Wu Y, Kurosaka H, Wang Q, et al. Retinoic acid deficiency underlies the etiology of midfacial defects. J Dent Res. 2022;101:686‐694.
Brandsch R. Microbiology and biochemistry of nicotine degradation. Appl Microbiol Biotechnol. 2006;69:493‐498.